KERREY J ROBERT sold (to issuer) $105K of THC
KERREY J ROBERT sold (to issuer) 607 shares of TENET HEALTHCARE CORP (THC) at $173.78 ($0.11M total) on 2026-05-22.
How this was made
The 30-second read
Why it matters
Because the disclosure is limited to share count, price, and a sale-to-issuer code (D), it does not provide new operational or financial information.
Market read
A disclosed insider sale to the issuer is typically low-signal; traders may only react if it contributes to a broader insider-selling trend.
What to watch
Assess whether there’s a pattern of director/officer selling across recent Form 4s; one-off sales are often non-informative.
Background
The filing is an SEC Form 4 insider transaction for Tenet Healthcare (THC), reporting a director sale to the issuer on 2026-05-22.
Ticker impact
Tenet Healthcare director Kerrey J. Robert sold 607 shares to the issuer for about $105.5K at $173.78/share, per SEC Form 4.
Minimal near-term impact; any move is more likely noise unless repeated insider selling accelerates.
Single small director transaction disclosed via Form 4, with no earnings/guidance/transaction details beyond the sale code and price.
Market effects
No direct sector read-across; insider Form 4s generally don’t reset healthcare/managed-care expectations.
None indicated.
None indicated.
Counterpoint
If insider sales to the issuer are part of a broader buyback program, the transaction may reflect liquidity/plan mechanics rather than negative views.
Key entities
- issuerTENET HEALTHCARE CORP
Subject of the Form 4 insider transaction; director Kerrey J. Robert sold 607 shares to the issuer.
- insiderKERREY J ROBERT
Director who sold shares to the issuer; holdings after transaction were 22,442 shares.
